Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: A review of the literature

Current Medical Research and Opinion

Volumn 22, Issue 11, 2006, Pages 2221-2232

  Bello, Alfonso E ^a   Oesser, Steffen ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Articular cartilage; Collagen hydrolysate; Nutritional supplements; Osteoarthritis; Proteoglycans; Type II collagen

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; CHONDROITIN SULFATE; COLLAGEN HYDROLYSATE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ARTHROPATHY; CARDIOVASCULAR DISEASE; CARTILAGE CELL; CLINICAL FEATURE; CLINICAL TRIAL; DATA BASE; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG MECHANISM; DRUG SCREENING; EXTRACELLULAR MATRIX; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HUMAN; MEDICAL LITERATURE; MEDLINE; METHYL SULFONYL METHANE; OSTEOARTHRITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PEPTIC ULCER; PHYSIOTHERAPY; PREVALENCE; REVIEW; RISK FACTOR; STROKE; SURGICAL TECHNIQUE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; CARTILAGE, ARTICULAR; COLLAGEN; DISEASE PROGRESSION; HUMANS; JOINT DISEASES; OSTEOARTHRITIS; PROTEIN HYDROLYSATES;

EID: 33751236765     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X148373     Document Type: Review

References (77)

1. Oliveria SA, Felson DT, Reed JI, et al. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995;38:1134-41
2. Brief AA, Maurer SG, Di Cesare PE. Use of glucosamine and chondroitin sulfate in the management of osteoarthritis. J Am Acad Orthop Surg 2001;9:71-8
3. Moskowitz RW. Role of collagen hydrolysate in bone and joint disease. Semin Arthritis Rheum 2000;30:87-99
4. Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988;10:1-28
5. Sharma L, Song J, Felson DT, et al. The role of knee alignment in disease progression and functional decline in knee osteoarthritis. J Am Med Assoc 2001;286:188-95
6. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133:635-46
7. Green GA. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone 2001;3:50-60
8. S. Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 1994;84:351-8
9. Prevalence of self-reported arthritis or chronic joint symptoms among adults - United States, 2001. MMWR Morb Mortal Wkly Rep 2002;51:948-50
10. Tesche F, Miosge N. New aspects of the pathogenesis of osteoarthritis: the role of fibroblast-like chondrocytes in late stages of the disease. Histol Histopathol 2005;20:329-37
11. Felson DT, Anderson JJ, Naimark A, et al. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med 1988;109:18-24
12. Coggon D, Reading I, Croft P, et al. Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord 2001;25:622-7
13. Pearle AD, Warren RF, Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med 2005;24:1-12
14. Kuettner KE, Aydelotte MB, Thonar EJ. Articular cartilage matrix and structure: a minireview. J Rheumatol Suppl 1991;27:46-8
15. Buckwalter JA, Mankin HJ. Articular cartilage. Part I: tissue design and chondrocyte-matrix interactions. Instr Course Lect 1998;47:477-86
16. Linn FC, Sokoloff L. Movement and composition of interstitial fluid of cartilage. Arthritis Rheum 1965;8:481-94
17. Maroudas A, Schneiderman R. 'Free' and 'exchangeable' or 'trapped' and 'non-exchangeable' water in cartilage. J Orthop Res 1987;5:133-8
18. Wroble R. Articular cartilage injury and autologous chondrocyte implantation: which patients might benefit? Phys Sports-med 2000;28:43-9
19. Lotz M, Blanco FJ, von Kempis J, et al. Cytokine regulation of chondrocyte functions. J Rheumatol Suppl 1995;43:104-8
20. Buckwalter JA. Activity vs. rest in the treatment of bone, soft tissue and joint injuries. Iowa Orthop J 1995;15:29-42
21. Buckwalter JA. Osteoarthritis and articular cartilage use, disuse, and abuse: experimental studies. J Rheumatol Suppl 1995;43:13-5
22. Gray ML, Pizzanelli AM, Grodzinsky AJ, Lee RC. Mechanical and physiochemical determinants of the chondrocyte biosynthetic response. J Orthop Res 1988;6:777-92
23. McAlindon TE, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996;39:648-56
24. Hadler NM, Gillings DB, Imbus HR, et al. Hand structure and function in an industrial setting. Arthritis Rheum 1978;21:210-20
25. Trippel SB. Growth factor actions on articular cartilage. J Rheumatol Suppl 1995;43:129-32
26. Trippel SB, Corvol MT, Dumontier MF, et al. Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes. Pediatr Res 1989;25:76-82
27. Lum ZP, Hakala BE, Mort JS, Recklies AD. Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta. J Cell Physiol 1996;166:351-9
28. Inoue H, Kato Y, Iwamoto M, et al. Stimulation of cartilage-matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor-beta. J Cell Physiol 1989;138:329-37
29. Morales TI. Transforming growth factor-beta and insulin-like growth factor-1 restore proteoglycan metabolism of bovine articular cartilage after depletion by retinoic acid. Arch Biochem Biophys 1994;315:190-8
30. Martin JA, Buckwalter JA. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002;3:257-64
31. Koepp H, Eger W, Muehleman C, et al. Prevalence of articular cartilage degeneration in the ankle and knee joints of human organ donors. J Orthop Sci 1999;4:407-12
32. Buckwalter JA, Lappin DR. The disproportionate impact of chronic arthralgia and arthritis among women. Clin Orthop Relat Res 2000:159-68
33. Buckwalter J, Goldberg V, Woo S-Y. Musculoskeletal soft-tissue aging: impact on mobility. Rosemont (IL): American Academy of Orthopedic Surgeons; 1993
34. DeGroot J, Verzijl N, Bank RA, et al. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum 1999;42:1003-9
35. Verzijl N, DeGroot J, Oldehinkel E, et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 2000;350:381-7
36. Brandt KD. Osteoarthritis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine, 15th ed. New York: McGraw-Hill; 2001
37. Felson DT, Hannan MT, Naimark A, et al. Occupational physical demands, knee bending, and knee osteoarthritis: results from the Framingham Study. J Rheumatol 1991;18:1587-92
38. Buckwalter JA, Lane NE. Athletics and osteoarthritis. Am J Sports Med 1997;25:873-81
39. Cushnaghan J, Dieppe P. Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis 1991;50:8-13
40. Dieppe P. Osteoarthritis: clinical and research perspective. Br J Rheumatol 1991;30(Suppl 1):1-4
41. Felson DT. Osteoarthritis. Rheum Dis Clin North Am 1990;16:499-512
42. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee [American College of Rheumatology]. Arthritis Rheum 1995;38:1541-6
43. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15
44. Towheed TE, Judd MJ, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2003:CD004257
45. Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006:CD004257
46. Hylek EM, Heiman H, Skates SJ, et al. Acetaminophen and other risk factors for excessive warfarin anticoagulation. J Am Med Assoc 1998;279:657-62
47. Lazzaroni M, Bianchi Porro G. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Aliment Pharmacol Ther 2004;20(Suppl 2):48-58
48. Garner SE, Fidan DD, Frankish RR, et al. Rofecoxib for rheumatoid arthritis. Cochrane Database Syst Rev 2005: CD003685
49. Anon. Annual nutrition industry overview. Nutrition Business J 2005;10:6-7
50. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. J Am Med Assoc 2000;283:1469-75
51. Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 1998;6(Suppl A):14-21
52. Setnikar I, Giacchetti C, Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung 1986;36:729-35
53. Bassleer C, Henrotin Y, Franchimont P. In-vitro evaluation of drugs proposed as chondroprotective agents. Int J Tissue React 1992;14:231-41
54. Vidal y Plana RR, Bizzarri D, Rovati AL. Articular cartilage pharmacology: I. In vitro studies on glucosamine and non steroidal antiinflammatory drugs. Pharmacol Res Commun 1978;10:557-69
55. McCarty MF. Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. Med Hypotheses 1998;50:507-10
56. Balkan B, Dunning BE. Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 1994;43:1173-9
57. Patti ME, Virkamaki A, Landaker EJ, et al. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 1999;48:1562-71
58. Shankar RR, Zhu JS, Baron AD. Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus. Metabolism 1998;47:573-7
59. Biggee BA, McAlindon T. Glucosamine for osteoarthritis: part II, biologic and metabolic controversies. Med Health R I 2004;87:180-1
60. Scroggie DA, Albright A, Harris MD. The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Arch Intern Med 2003;163:1587-90
61. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New Engl J Med 2006;354:795-808
62. Biggee BA, McAlindon T. Glucosamine for osteoarthritis: part I, review of the clinical evidence. Med Health R I 2004;87:176-9
63. McAlindon T. Why are clinical trials of glucosamine no longer uniformly positive? Rheum Dis Clin North Am 2003;29:789-801
64. Kim LS, Axelrod LJ, Howard P, et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage 2006;14:286-94
65. Harmand MF, Vilamitjana J, Maloche E, et al. Effects of S-adenosylmethionine on human articular chondrocyte differentiation. An in vitro study. Am J Med 1987;83(Suppl 5A):48-53
66. Oesser S, Seifert J. Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen. Cell Tissue Res 2003;311:393-9
67. Data on file, GELITA Health Products, Vernon Hills, Illinois 2006
68. Krug E. Zur unterstützenden Therapie bei Osteo- und Chondropathien. Z Erfahrungsheikunde 1979;11:930-8
69. Götz B. Gut genährter Knorpel knirscht nicht mehr. Ärztl Prax 1982;92:3130-4
70. Oberschelp U. Individuelle Arthrosetherapie ist möglich. Therapiewoche 1985;44:5094-7
71. Adam M. Welche Wirkung haben Gelatinepräparate? Ther Osteoarthrose Therapiewoche 1991;41:2456-61
72. Flechsenhar K, Alf D. Ergebnisse einer Anwendungsbeobachtung zu Kollagen-Hydrolysat CH-Alpha. Orthopaedische Praxis 2005;9:486-94
73. Zukley L, Angelopoulos K, Carpenter M, et al. Collagen hydrolysate improves joint function in adults with mild symptoms of osteoarthritis of the knee. 51st Annual American College of Sports Medicine 2004 [poster]
74. Oesser S, Adam M, Babel W, Seifert J. Oral administration of (14)C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL). J Nutr 1999;129:1891-5
75. Oesser S. Degraded collagen modulates the internal remodeling of cartilage extracellular matrix. Arthritis Rheum 2005;52(Suppl 9):S62
76. Zuckley L, Angelopoulou K, Carpenter MR, et al. Collagen hydrolysate improves joint function in adults with mild symptoms of osteoarthritis of the knee. Med Sci Sports Exerc 2004;36(Suppl):S153-S154
77. Selbmann H-K, Fischer IU, Moskowitz RW. Collagen hydrolysate in knee osteoarthritis (OA): population specific responses. Poster at The Congress of the Osteoarthritis Research Society International (OARSI) 2004